Breathe Well Live Well
Condition: Asthma
Interventions: Drug: terbutaline sulphate delivered dose; Drug: terbutaline sulphate metered dose
Sponsor: AstraZeneca
Not yet recruiting – verified June 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
 |
Related Articles |
Specific inhalation challenge tests for occupational asthma in Europe: a survey.
Eur Respir Rev. 2014 Jun;23(132):266-70
Authors: Suojalehto H, Cullinan P, European Respiratory Society Task Force on Specific Inhalation Challenges with Occupational Agents
PMID: 24881084 [PubMed – in process]
View full post on pubmed: asthma
|
Inhalation best for asthma
The Hindu Asthma, the chronic inflammation of airways, is a problem seen the world over. It is estimated that three crore people are affected world wide. However, the disease can be controlled and does not turn fatal in most cases, professor of pulmonlogy in … |
View full post on asthma – Google News
Conditions: Asthma; Chronic Obstructive Pulmonary Disease
Intervention: Other: Inhalation technique training
Sponsor: Medical University of Warsaw
Recruiting – verified May 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Asthma; COPD
Intervention:
Sponsor: Elpen Pharmaceutical Co. Inc.
Not yet recruiting – verified January 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Regular follow up key to asthma inhalation technique
medwireNews medwireNews: Researchers in Turkey have found that regular follow up and correction of inhaler technique significantly improves patient asthma control over 6 months. “Our findings emphasize the crucial role of regular assessment and reinforcement of … |
View full post on asthma – Google News
|
Acton Says FDA Oks SNDA For AEROSPAN Inhalation Aerosol For Asthma
RTT News … has approved the sNDA (Supplemental New Drug Application) for AEROSPAN Inhalation Aerosol, a hydrofluoroalkane orally inhaled corticosteroid indicated for the maintenance treatment of asthma as a prophylactic therapy in adult and pediatric patients … |
View full post on asthma – Google News
|
Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge …
Sacramento Bee ARIDOL, the only dry powder bronchial challenge test approved for use in the United States, is used to assess bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. ARIDOL should not be used as … |
View full post on asthma – Google News
|
Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge …
PR Newswire (press release) ARIDOL, the only dry powder bronchial challenge test approved for use in the United States, is used to assess bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. ARIDOL should not be used as … |
View full post on asthma – Google News
|
Pharmaxis Receives J-Code For ARIDOL® (Mannitol Inhalation Powder) Bronchial …
MarketWatch (press release) ARIDOL should not be used as a stand alone test to assess asthma or as a screening test for asthma, but as part of a physician's overall assessment of asthma. The new J-code becomes effective on January 1, 2012. J-codes are used by providers to bill … |
View full post on asthma – Google News